These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7129708)

  • 41. Statement and resolution regarding methadone maintenance treatment. Subcommittee on Drug Abuse, Committee on Public Health of the New York Academy of Medicine.
    Bull N Y Acad Med; 1982 Sep; 58(6):579-84. PubMed ID: 6959682
    [No Abstract]   [Full Text] [Related]  

  • 42. Dose-response effects of methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Ann Intern Med; 1993 Jul; 119(1):23-7. PubMed ID: 8498759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
    Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diacetylmorphine versus methadone for opioid addiction.
    Reece AS
    N Engl J Med; 2009 Nov; 361(22):2194-5; author reply 2195. PubMed ID: 19950413
    [No Abstract]   [Full Text] [Related]  

  • 45. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
    Harris A; Selling D; Luther C; Hershberger J; Brittain J; Dickman S; Glick A; Lee JD
    Subst Abus; 2012; 33(1):70-5. PubMed ID: 22263715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating primary care and methadone maintenance treatment: implementation issues.
    Herman M; Gourevitch MN
    J Addict Dis; 1997; 16(1):91-102. PubMed ID: 9046446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating the drug abuser.
    Doyle KM; Quinones MA; Louria DB
    Public Health Rev; 1982; 10(1):77-98. PubMed ID: 6813913
    [No Abstract]   [Full Text] [Related]  

  • 48. Sociodemographic disparities in supplemental service utilization among male methadone patients.
    Wu E; El-Bassel N; Gilbert L; Piff J; Sanders G
    J Subst Abuse Treat; 2004 Apr; 26(3):197-202. PubMed ID: 15063913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China.
    Che Y; Assanangkornchai S; McNeil E; Chongsuvivatwong V; Li J; Geater A; You J
    Drug Alcohol Rev; 2010 May; 29(3):263-70. PubMed ID: 20565518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profile of active and terminated patients in a methadone maintenance program.
    Quatrone D
    Proc Natl Conf Methadone Treat; 1973; 1():760-6. PubMed ID: 4808230
    [No Abstract]   [Full Text] [Related]  

  • 51. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
    Kellogg SH; Burns M; Coleman P; Stitzer M; Wale JB; Kreek MJ
    J Subst Abuse Treat; 2005 Jan; 28(1):57-65. PubMed ID: 15723733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contingent methadone delivery: effects on illicit-opiate use.
    Higgins ST; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1986 Jul; 17(4):311-22. PubMed ID: 3757767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methadone maintenance treatment. Five years later--where are they now?
    Gearing FR
    Am J Public Health; 1974 Dec; 64 Suppl 12(12 Suppl):44-50. PubMed ID: 4429175
    [No Abstract]   [Full Text] [Related]  

  • 54. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
    Strike CJ; Gnam W; Urbanoski K; Fischer B; Marsh DC; Millson M
    Addict Behav; 2005 Jun; 30(5):1025-8. PubMed ID: 15893099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
    Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
    Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methadone maintenance. New research on a controversial treatment.
    Glass RM
    JAMA; 1993 Apr; 269(15):1995-6. PubMed ID: 8464135
    [No Abstract]   [Full Text] [Related]  

  • 59. The criminal justice system and opiate addiction: a historical perspective.
    Joseph H
    NIDA Res Monogr; 1988; 86():106-25. PubMed ID: 3140027
    [No Abstract]   [Full Text] [Related]  

  • 60. A primary care/multidisciplinary harm reduction clinic including opiate bridging.
    Ross D; Lo F; McKim R; Allan GM
    Subst Use Misuse; 2008; 43(11):1628-39. PubMed ID: 18752164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.